Immunotherapy may hold the key to defeating virally associated cancersNovember 25, 2018Head & Neck/Thyroid CancersGenitourinary CancerGynecologic CancerGastroenterologyImmunotherapyLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Immunotherapy-related adverse effects: how to identify and treat them in the emergency departmentAugust 26, 2018ImmunotherapyPatient & Survivor Care
Meeting the potential of immunotherapy: new targets provide rational combinationsAugust 15, 2018GastroenterologyBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersImmunotherapyLymphoma & Plasma Cell DisordersMelanoma
Immunotherapies shape the treatment landscape for hematologic malignanciesAugust 15, 2018Lymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationImmunotherapy
Tumor heterogeneity: a central foe in the war on cancerJune 21, 2018ImmunotherapyPatient & Survivor Care
An ASCO 2017 recap: significant advances continueSeptember 8, 2017Breast CancerGenitourinary CancerGastroenterologyPatient & Survivor CareImmunotherapy
Pancreatitis associated with newer classes of antineoplastic therapiesJuly 25, 2017Patient & Survivor CareImmunotherapy
Palmoplantar exacerbation of psoriasis after nivolumab for lung cancerMay 17, 2017Lung CancerPatient & Survivor CareImmunotherapy
Split-dose R-CHOP: a new approach to administer cytotoxic chemo-immunotherapy to elderly patients with DLBCLNovember 22, 2016Lymphoma & Plasma Cell DisordersImmunotherapy
Lessons learned from using CDK 4/6 inhibitors to treat metastatic breast cancerNovember 3, 2016Breast CancerPatient & Survivor CareImmunotherapy
Slow and steady progress in managing gynecologic cancer August 24, 2016Gynecologic CancerImmunotherapy
Evolving therapeutic strategies maintain clinical momentum in melanomaJune 29, 2016MelanomaImmunotherapy
More success for immunotherapy with nivolumab approval for metastatic RCCApril 27, 2016Genitourinary CancerImmunotherapy
Encouraging data on immunotherapy, cardiotoxicity, and DFSFebruary 21, 2016Breast CancerImmunotherapy
Making immunotherapy part of routine breast cancer treatmentFebruary 21, 2016Breast CancerPatient & Survivor CareImmunotherapy
